Kaisheng New Materials (301069.SZ): Currently not directly involved in the field of synthetic biology
Gelonghui, May 9 | Kaisheng New Materials (301069.SZ) said on the investor interactive platform that the company has not yet directly entered the field of synthetic biology. The company firmly focuses on the “one chain, two wings” enterprise development strategy, continuously improves products based on the sulfoxide chloride industry chain, and vigorously expands products in the field of new materials and new energy downstream.
Kaisheng New Materials (301069.SZ): No direct production of terephthalic anhydride (TMA) products
Gelonghui, May 9 | Kaisheng New Materials (301069.SZ) said on the investor interactive platform that the company has not directly produced terephthalic anhydride (TMA) products. Currently, the company purchases terephthalic trianhydride products to synthesize terephthalic anhydride acyl chloride products, and downstream is mainly used in the fields of medicine, medicine, and new materials.
Kaisheng New Materials (301069): Aramid polymer monomer, excellent profitability, PEKK can be expected to grow
Incident description Incident: On April 20, Kaisheng New Materials released its 2024 quarterly report. The company achieved revenue of 240 million yuan in Q1, -3.3% year-on-year, and achieved net profit of 25.698 million yuan to mother, -49 yuan.
Kaisheng New Materials (301069.SZ): Net profit of 256.984 million yuan in the first quarter decreased by 49.29% year-on-year
Gelonghui, April 19 | Kaisheng New Materials (301069.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 239.9 million yuan, down 3.26% year on year; net profit attributable to shareholders of listed companies was 25.6984 million yuan, down 49.29% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 21.6792 million yuan, down 56.87% year on year; basic earnings per share were 0.0611 yuan.
Kaisheng New Materials (301069.SZ) plans to pay 1.5 yuan for 10 shares to be deducted from interest on April 25
Kaisheng New Materials (301069.SZ) announced that the company's 2023 equity distribution plan: every 10 shares to all shareholders...
Tianfeng Securities: AI empowers humanoid robots PEEK and carbon fiber or welcome new growth poles
The trend of replacing PEEK in domestic production is obvious, and the application of PEEK in Tesla robots brings new demand.
Kaisheng New Materials (301069.SZ): No direct production of terephthalic anhydride products
Gelonghui, April 16 | Kaisheng New Materials (301069.SZ) said on the investor interactive platform that the company has not directly produced terephthalic anhydride products. Currently, the company purchases terephthalic trianhydride products to synthesize terephthalic anhydride acyl chloride products, and downstream is mainly used in the fields of medicine, medicine, and new materials.
The terephthalic anhydride concept rose in the afternoon, and Huajin Co., Ltd. rose and stopped in a straight line. Previously, Zhengdan Shares and Baichuan Co., Ltd. broke out of 2 consecutive markets, while Yida Co., Ltd., Kaisheng New Materials, and Ji
The terephthalic anhydride concept rose in the afternoon, and Huajin Co., Ltd. rose and stopped in a straight line. Previously, Zhengdan Shares and Baichuan Co., Ltd. broke out of 2 consecutive markets, while Yida Co., Ltd., Kaisheng New Materials, and Jiaao Environmental Protection rose more than 6%.
Express News | Kaisheng New Materials: Can supply high-quality aramid polymer monomers to aramid fiber manufacturers
Express News | Kaisheng New Materials: The company's PEKK products have been used by customers in general profiles, spraying and other fields
Kaisheng New Materials (301069.SZ): PEKK products are currently used by customers in the fields of general profiles, spraying, etc.
Gelonghui March 25 | Kaisheng New Materials (301069.SZ) held a performance briefing on March 25, 2024 to discuss “What customers need PEKK/PEEK materials in the fields of aerospace, robotics, 3D printing, new energy vehicles/automobiles, medical materials, etc., and has your company begun to explore a larger and larger market for this competitive engineering plastic material?” The company replied that the company's PEKK products are currently being used by customers in the fields of general profiles, painting, etc., and the company is also developing markets in aerospace, human implants, 3D printing, and robotics.
Kaisheng New Materials (301069.SZ): Weifang Company is currently constructing a 20,000 ton aramid polymer monomer project
Gelonghui March 25 丨 Kaisheng New Materials (301069.SZ) held a performance briefing on March 25, 2024 to discuss “How is Weifang Factory planning for the future?” The company replied that Weifang is currently constructing a 20,000 ton aramid polymer monomer project, and the company will continue to lay out products around the company's industrial chain in the future.
Kaisheng New Materials (301069.SZ): supplies terephthalyl chloride products to DuPont in the United States
Gelonghui March 25 丨 Kaisheng New Materials (301069.SZ) held a performance briefing on March 25, 2024 to discuss “Are the aramid products produced by the company raw materials for bulletproof vests and military helmets, and are aramid products imported by DuPont used in military products?” The company replied that the terephthalyl chloride produced by the company is the main raw material for synthetic aramid 1414, and aramid 1414 can be used to prepare bulletproof vests and bulletproof helmets. DuPont of the United States is the company's overseas customers, and the company supplies terephthalyl chloride products to them.
Kaisheng New Materials (301069.SZ): It has established good cooperative relationships with high-quality downstream customers such as DuPont of the United States, Teijin of Japan, Colon Korea, Taihe New Materials, and Sinochem Hi-Fiber
Gelonghui March 25 丨 Kaisheng New Materials (301069.SZ) held a performance briefing on March 25, 2024 to discuss “What are the company's major customers?” The company replied that the company has established good cooperative relationships with high-quality downstream customers such as DuPont of the United States, Teijin of Japan, Colon Korea, Taihe New Materials, and Sinochem Hi-Fiber. For other customer situations, please refer to the regular reports disclosed by the company.
Kaisheng New Materials (301069.SZ): Production is currently normal, and the overall price of raw materials has not fluctuated much
Gelonghui March 25 丨 Kaisheng New Materials (301069.SZ) held a performance briefing on March 25, 2024 to discuss “How is the company's capacity absorption this year? Has the fluctuation in raw material prices improved?” The company replied that the company's production is currently normal, and the overall price of raw materials has not fluctuated much.
Kaisheng New Materials (301069): Performance meets expectations, new projects drive growth
Brief performance review On March 15 and March 20, the company released the 2023 annual report and annual report corrections respectively. The company achieved revenue of 987 million yuan in 2023, -2.33% year-on-year; net profit of 1.5 million yuan
Kaisheng New Materials (301069): Sulfoxide chloride is weak, performance is under pressure, and PEKK aramid monomer growth can be expected
Incident description On the evening of March 14, 2024, Kaisheng New Materials released its 2023 annual report. The company's revenue in 2023 was 987 million yuan, a year-on-year decrease of 2.33%; net profit to mother was 158 million yuan.
Kaisheng New Materials (301069): Sulfoxide chloride is under pressure, new products and new production capacity are gradually being released
Incident: On March 14, 2024, the company released its 2023 annual report. It achieved revenue of 987 million yuan for the full year of 2023, -2.33% year on year; net profit to mother was 158 million yuan, -32 yuan year on year.
Kaisheng New Materials (301069.SZ): Net profit for 2023 fell 32.63% to 158 million yuan, and plans to pay 10 to 1.5 yuan
Gelonghui March 14 | Kaisheng New Materials (301069.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 987 million yuan, a year-on-year decrease of 2.33%; net profit attributable to shareholders of listed companies was 158 million yuan, a year-on-year decrease of 32.63%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 152 million yuan, a year-on-year decrease of 32.93%; basic income per share was 0.3756 yuan; it plans to distribute a cash dividend of 1.50 yuan (tax included) to all shareholders for every 10 shares.
Huabang Health (002004.SZ): The holding subsidiary Kaisheng New Materials is mainly engaged in R&D, production and sales of fine chemical products and new polymer materials
Gelonghui, March 13 | Huabang Health (002004.SZ) said on the investor interactive platform that the company's holding subsidiary Kaisheng New Materials is mainly engaged in R&D, production and sales of fine chemical products and novel polymer materials. The business covers inorganic chemicals, carboxyl chlorides, hydroxychlorides, and the novel polymer material polyether ketone. The main products include inorganic chemicals (including sulfoxide chloride and sulfuryl chloride), carboxyl chloride (including aramid polymer monomers, para-nitrobenzoyl chloride, chloroacetyl chloride, etc.), hydroxychlorides (including chloroacetyl chloride, etc.), hydroxychlorides (including chloroacetyl chloride, etc.), hydroxy chlorides (including chloroacetyl chloride, etc.), and polychlorochlorides (including polychlorinated polymers) ether ketone ketone, etc.
No Data